Although we identified elevated IL-10R2+ cells and typical mRNA signatures in our PDAC patients, cases showing recurrence and a mouse model of pancreatic cancer, a large-scale population-based prospective study is needed to confirm the clinical utility of these cells for screening the general population. This evidence concerns the gene IL10RB and familial pancreatic carcinoma.